Targeting pro-dopaminergic agonism to attenuate and depression in patient's displaying genetic/epigenetic predisposition to hypodopaminergia.

IF 3.4 3区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Frontiers in Public Health Pub Date : 2025-09-25 eCollection Date: 2025-01-01 DOI:10.3389/fpubh.2025.1594872

Kai-Uwe Lewandrowski, Kenneth Blum, Alexander P L Lewandrowski, Panayotis K Thanos, Albert Pinhasov, Alireza Sharafshah, David Baron, Mark S Gold, Catherine A Dennen, Igor Elman, Aballa Bowirrat, Edward J Modestino, Foojan Zeine, Nicole Jafari, Keerthy Sunder, Milan T Makale, John Giordano, Marjorie C Gondre-Lewis, Marco Lindenau, Brian S Fuehrlein, Rajendra D Badgaiyan, Chynna Levin, Sergio Luis Schmidt, Rossano Kepler Alvim Fiorelli

引用次数: 0

Abstract Image

查看原文本刊更多论文

以前多巴胺能激动作用为目标，减轻表现出遗传/表观遗传低多巴胺能易感性的患者的抑郁。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers in Public Health Medicine-Public Health, Environmental and Occupational Health

CiteScore

4.80

自引率

7.70%

发文量

4469

审稿时长

14 weeks

期刊介绍： Frontiers in Public Health is a multidisciplinary open-access journal which publishes rigorously peer-reviewed research and is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians, policy makers and the public worldwide. The journal aims at overcoming current fragmentation in research and publication, promoting consistency in pursuing relevant scientific themes, and supporting finding dissemination and translation into practice. Frontiers in Public Health is organized into Specialty Sections that cover different areas of research in the field. Please refer to the author guidelines for details on article types and the submission process.